Phenylbutyrate has been demonstrated to have independent effects on ER stress and inhibition of histone deacetylase [10], both therapeutic targets in PAH and therefore of potential relevance outside of BMPR2-PAH. Here, BMPR2 is linked to pulmonary arterial hypertension.